ECULIZUMAB Pharmacologic Class Indexing
- Class set ID
- bc258be1-b34f-43c7-a657-b468b372feec
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use EPYSQLI safely and effectively. See full prescribing information for EPYSQLI. EPYSQLI ® (eculizumab-aagh) injection, for intravenous use Initial U.S. Approval: 2024 EPYSQLI (eculizumab-aagh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe | Teva Pharmaceuticals USA, Inc. | 20260415 | 4 |
| These highlights do not include all the information needed to use BKEMV safely and effectively. See full prescribing information for BKEMV. BKEMV ® (eculizumab-aeeb) injection, for intravenous use Initial U.S. Approval: 2024 BKEMV (eculizumab-aeeb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the b | Amgen Inc | 20251201 | 7 |
| These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS ® (eculizumab) injection, for intravenous use Initial U.S. Approval: 2007 | Alexion Pharmaceuticals Inc. | 20250307 | 42 |
| 1944fe02-2140-486a-967c-ad54bb2a479a | | | -1 |